947
Participants
Start Date
June 30, 2006
Primary Completion Date
December 31, 2006
Study Completion Date
December 31, 2006
Dexlansoprazole MR
Dexlansoprazole MR 30 mg, capsules, orally, once daily for 4 weeks.
Dexlansoprazole MR
Dexlansoprazole MR 60 mg, capsules, orally, once daily for 4 weeks.
Placebo
Dexlansoprazole placebo-matching capsules, orally, once daily for 4 weeks.
Alabaster
Birmingham
Hueytown
Huntsville
Northport
Tallassee
Chandler
North Little Rock
Sun City
Tempe
Tucson
Anaheim
Azusa
Carmichael
Chula Vista
Clearwater
Cypress
Fountain Valley
Fullerton
Garden Grove
Irvine
Lancaster
Mission Hills
Oakland
Orange
Palm Springs
Pasadena
Redwood City
San Diego
San Francisco
San Luis Obispo
Vista
Westlake Village
Boulder
Colorado Springs
Littleton
Lone Tree
Wheat Ridge
Bristol
Waterbury
Boynton Beach
Clearwater
Holly Hill
Jupitor
Kissimmee
Miami
Naples
New Smyma Beach
Ocala
Pembroke Pines
St. Petersburg
West Palm Beach
Zephyrhills
Atlanta
Conyers
Dunwoody
Stockbridge
Honolulu
Boise
Moline
Oak Forrest
Rockford
Indianapolis
Clive
Dubuque
Overland
Wichita
Lexington
Louisville
Baton Rouge
Metairie
Baltimore
Chevy Chase
Hollywood
Lutherville
Prince Frederick
Troy
Chaska
Jackson
Olive Branch
Jefferson City
Mexico
Washington
Butte
Las Vegas
Pahrump
Egg Harbor Town
Albuquerque
Binghamton
Great Neck
Rochester
Charlotte
Greensboro
Harrisburg
High Point
Raleigh
Statesville
Bismarck
Cincinnati
Cleveland
Columbus
Dayton
Franklin
Kettering
Lyndhurst
Mogadore
Sylvania
Oklahoma City
Medford
Portland
Duncansville
Harleysville
Lansdale
Levittown
Anderson
Charleston
Mt. Pleasant
Varnville
Sioux Falls
Bristol
Chattanooga
Germantown
Hermitage
Jackson
Johnson City
Kingsport
Nashville
Amarillo
Austin
Beaumont
Bellaire
Bryan
Carollton
Conroe
Corsicana
Dallas
El Paso
Fort Worth
Houston
Lake Jackson
San Antonio
Midvale
Ogden
Salt Lake City
Charlottesville
Chesapeake
Norfold
Richmond
Lakewood
Spokane
Tacoma
Milwaukee
Monroe
Lead Sponsor
Takeda
INDUSTRY